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Purpose: To define the phenotype and elucidate the molecular basis for an autosomal recessively inherited optic atrophy
and auditory neuropathy in a consanguineous family with two affected children.
Methods: Family members underwent detailed ophthalmologic, electrophysiological, and audiological assessments. An
autozygosity mapping strategy using high-density single nucleotide polymorphism microarrays and microsatellite markers
was used to detect regions of genome homozygosity that might contain the disease gene. Candidate genes were then
screened for mutations by direct sequencing.
Results: Both affected subjects had poor vision from birth and complained of progressive visual loss over time. Current
visual acuity ranged from 6/60 to 6/120. Fundus examination revealed bilateral temporal optic nerve pallor in both patients
with  otherwise  normal  retinal  findings.  International-standard  full-field  electroretinograms  were  normal  in  both
individuals, with no evidence of generalized retinal dysfunction. Pattern cortical visual evoked potentials were grossly
abnormal bilaterally in both cases. The pattern electroretinogram N95:P50 ratio was subnormal, and the P50 was of
shortened peak time bilaterally in both patients. The electrophysiological findings were consistent with bilateral retinal
ganglion cell/optic nerve dysfunction. Audiological investigation in both siblings revealed abnormalities falling within
the auditory neuropathy/dysynchrony spectrum. There were no auditory symptoms and good outer hair cell function (as
demonstrated by transient evoked otoacoustic emissions) but impaired inner hair cell/neural function with abnormal
stapedial  reflex  thresholds  and  abnormal  or  absent  auditory  brainstem-evoked  responses.  The  single  nucleotide
polymorphism microarray data demonstrated a 24.17 Mb region of homozygosity at 11q14.1–11q22.3, which was
confirmed by microsatellite marker analysis. The candidate target region contained the transmembrane protein 126A
(TMEM126A) gene, and direct sequencing identified a previously described nonsense mutation (c.163C>T; p.Arg55X).
Conclusions: We describe the first detailed phenotyping of patients with autosomal recessive TMEM126A-associated
optic atrophy and auditory neuropathy. These findings will facilitate the identification of individuals with this recently
described disorder.
Primary hereditary optic neuropathies comprise a group
of disorders that are characterized by visual loss due to retinal
ganglion  cell  death.  The  most  common  forms  of  optic
neuropathy are Leber hereditary optic neuropathy (LHON)
with  mitochondrial  transmission  (OMIM  535000)  and
autosomal  dominant  optic  atrophy  (OMIM  165500)  [1].
Autosomal recessive optic neuropathies are uncommon and
are mostly observed in association with multisystem diseases.
A few cases of isolated autosomal recessive optic atrophy
have been reported [2]. Previously Barbet et al. [3] mapped a
locus for early onset but slowly progressive optic neuropathy
(OPA6; OMIM 258500) to chromosome 8q. Affected family
members  presented  with  visual  impairment  commencing
between 2 and 6 years of age, moderate photophobia, and
dyschromatopsia. There were no associated systemic features.
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Recently,  Hanein  et  al.  [4]  identified  a  second  locus  for
autosomal recessive optic atrophy on chromosome 11 and
identified germline mutations in transmembrane protein 126A
gene (TMEM126A) in affected individuals from four families.
Autosomal  recessive  auditory  neuropathy  has  been
reported  in  association  with  mitochondrial  myopathy  and
mitochondrial DNA multiple deletions [5], but commonly it
presents as congenital nonsyndromic hearing impairment as a
consequence of mutations in the otoferlin (OTOF) gene, a
membrane-anchored calcium-binding protein that plays a role
in the exocytosis of synaptic vesicles at the auditory inner hair
cell ribbon synapses [6]. Nonsyndromic autosomal recessive
auditory neuropathy has also been reported in association with
missense mutations in the autosomal recessive deafness 59
gene  on  chromosome  2q31.1-q31.3,  which  encodes  the
protein pejvakin found in hair cell, supporting cells, spiral
ganglion cells, and the first three relays of the afferent auditory
pathway [7].
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651The  co-occurrence  of  optic  neuropathy  and  auditory
neuropathy is rare, but two cases of LHON with auditory
neuropathy have been reported [8], although a more recent
study has documented that this is an uncommon finding in
LHON [9]. The X-linked recessive deafness-dystonia-optic
neuronopathy  syndrome  (Mohr-Tranebjaerg  syndrome;
OMIM 304700) is characterized by postlingual sensorineural
hearing  loss  in  early  childhood,  with  progressive  neural
degeneration affecting the brain, eighth cranial nerve, and
optic  nerves  in  adult  life.  The  auditory  findings  indicate
auditory  neuropathy,  with  spiral  ganglion  cells  being  the
suspected site of pathology. The X-linked recessive deafness-
dystonia-optic neuronopathy is caused by mutations in the
translocase of inner mitochondrial membrane 8 homolog A
(yeast) gene which is also called deafness/dystonia peptide
gene and encodes for a 97 amino acid polypeptide [10].
We  report  the  results  of  detailed  clinical,
electrophysiological,  audiological,  and  molecular  genetic
investigations in a family with optic atrophy associated with
a mutation in TMEM126A. Our findings suggest that auditory
neuropathy  may  be  an  additional  previously  unreported
feature of this disorder.
METHODS
Patients: A consanguineous family of Algerian origin with
two  affected  children  was  ascertained  and  recruited  for
clinical  and  molecular  genetic  studies.  All  subjects  gave
written informed consent. The study was approved by the
South Birmingham Local Research Ethics Committee and
was  performed  in  accordance  with  the  Declaration  of
Helsinki. Genomic DNA from the two affected individuals,
two unaffected siblings, and the parents were extracted from
peripheral lymphocytes by standard techniques.
Ocular assessment: Both affected siblings (IV:1 and IV:2)
were examined. A medical and ophthalmic history was taken,
and a full ophthalmologic examination was performed. Color
vision was tested using Ishihara pseudoisochromatic plates
and  Hardy,  Rand  and  Rittler  plates  (American  Optical
Figure 1. Fundal appearance. Color fundus photographs of both eyes of the two affected siblings. Bilateral temporal optic disc pallor and
normal retinal appearance (IV:1 above and IV:2 below) are seen.
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652Company, New York, NY). Each patient underwent color
fundus photography, Goldmann perimetry (Haag-Streit AG,
Bern, Switzerland), and retinal nerve fiber layer analysis using
the Zeiss Stratus® OCT 3 (Carl Zeiss Meditec Inc., Dublin,
CA).  Both  patients  had  detailed  electrophysiological
assessment, including a full-field electroretinogram (ERG)
Figure 2. Retinal nerve fiber layer analysis. The results of this analysis demonstrates the marked global reduction in nerve fiber layer thickness
compared to normative values (using the Zeiss Stratus® OCT 3) in Patient IV:1.
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653and pattern ERG, incorporating the protocols recommended
by the International Society for Clinical Electrophysiology of
Vision [11,12]. Cortical visual evoked potentials (VEPs) were
recorded to high contrast checkerboard reversal (field size
12°×15° or 24°×30°, check size 0.9°, reversal rate 2.2 Hz) and
diffuse flash stimulation.
Figure 3. International-standard full-field electroretinogram of the two affected individuals of the optic atrophy family. This figure shows the
electroretinogram (ERGs) from the right (row 1) and left (row 2) eye of patient IV:2, from the right (row 3) and left (row 4) eye of patient IV:
1, and typical normal examples for comparison (row 5, bottom row). Dark-adapted ERGs are shown for flash intensities of 0.01 and 11.5 cd
seconds per square meter (cd.s.m−2); light adapted ERGs are shown for 30 Hz flicker and 2 Hz stimulation at a flash intensity of 3.0 cd.s.m
−2. ON-OFF ERGs used an orange stimulus (560 cds per square meter [cd.m−2], duration 200 ms) superimposed on a green background (150
cd.m−2). S-cone ERGs used a blue stimulus (445 nm, 80 cd.m−2) on an orange background (620 nm, 560 cd.m−2). Broken lines replace blink
artifacts occurring just after the b-wave peak in patient IV:1.
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654Figure 4. Pattern cortical visual evoked
potentials, flash cortical visual evoked
potentials,  and  pattern
electroretinograms of the two affected
individuals  with  mutation  in  the
transmembrane protein 126A gene. In
row 1 are the results from the right and
in row 2 from the left eye of patient IV:
2, in row 3 from the right and in row 4
from the left eye of patient IV:1, and in
row 5 and the bottom row from normal
examples  for  comparison.  Illustrated
pattern cortical visual evoked potentials
(VEPs) from patient IV:2 were recorded
to a large checkerboard field (24°×30°);
those from patient IV:1 were recorded
to  a  standard  checkerboard  field
(12°×15°).
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655Audiological assessment: Both siblings underwent a detailed
otological  examination  and  showed  normal  tympanic
membranes and tuning fork tests. Standard air conduction
pure tone audiometry [13] was conducted in a sound-treated
booth, using a GSI 61 audiometer (Model 61; Grason Stadler
Inc.,  Eden  Prairie,  MN)  and  TDH  39  headphones
(Interacoustic A/S, Assens, DK).
Single frequency tympanometry was performed with a
probe signal, an 85 dB sound pressure level (SPL) continuous
tone at 226 Hz [13], using a GSI 33 Tympanometer (Model
33; Grason Stadler Inc.). Stapedial reflex thresholds were
measured  both  ipsilaterally  and  contralaterally,  using  the
method described by Cohen and Prasher [14].
Transient evoked otoacoustic emissions were recorded
from  each  ear  using  an  Otodynamics  ILO92  analyzer
(Otodynamics Ltd., Hartfield, UK) [15]. A standard nonlinear
click stimulus of 80 µs duration was presented at a repetition
rate of 50 Hz and an intensity of 80 (±3) dB SPL. The response
was averaged over 260 acquisitions, and the total (mean)
nonlinear transient evoked otoacoustic emissions (TEOAE)
response amplitude (dB SPL) was analyzed.
Brainstem-evoked  potentials  were  recorded  using  a
Medelec  Sensor  ST10.  Standard  electroencephalogram
(EEG) silver/silver chloride disc electrodes were attached to
each  mastoid  process-A1  and  A2  and  to  the  vertex-Cz.
Electrode  impedance  was  less  than  5  kΩ.  An  alternating
polarity click stimulus of 100 µs electrical duration at an
intensity of 90 dBHL was presented via TDH-39 headphones
at a repetition rate of 10 Hz. Broadband noise at 50 dBHL was
used in the contralateral ear. The analysis was confined to
latencies and interwave latencies of waves I, III, and V. The
analysis of the conduction latencies was considered abnormal
if the value exceeded 2 standard deviations (SDs) from the
normal mean or if the responses were unrepeatable or absent.
Absolute interaural wave V latencies were also analyzed and
were considered to be abnormal if the latency difference of
wave  V  was  greater  than  2  standard  deviations  from  the
normal mean.
Linkage  analysis:  A  genome-wide  linkage  scan  using
Affymetrix  250K  Sty1  single  nucleotide  polymorphism
(SNP)  mapping  arrays  according  to  the  manufacturer’s
instruction  (Affymetrix,  Inc.,  Santa  Clara,  CA)  was
Figure 5. Pure tone audiometry. Pure
tone audiometry (250–8000 Hz) in the
two  affected  siblings.  The  initial
recording is shown as a dashed line, and
the second recording (about 1 year later)
as a solid line. A: This panel shows pure
tone audiometric thresholds of over a 1-
year  period  of  patient  IV:1.  B:  This
panel  shows  pure  tone  audiometric
thresholds of over an 18-month period
of patient IV:2.
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656undertaken  in  all  siblings  to  identify  shared  regions  of
homozygosity (>2 Mb) in the affected individuals. Briefly, the
DNAs (250 ng each) were first digested with Sty1 restriction
enzyme (New England Biolabs, Boston, MA) and then ligated
to adaptors. Each Sty1 adaptor-ligated DNA was amplified in
three  100  µl  PCR  reactions  using  AmpliTaq  Platinum
(Clontech  Laboratories,  Inc.,  Palo  Alto,  CA).  Fragmented
PCR products were then labeled, denatured and hybridized to
the  array  following  washing  and  staining  steps  on  the
Affymetrix  GeneChip  fluidics  station  450.  Fluorescence
intensities were quantified with an Affymetrix array scanner
3000–7G  and  the  data  were  collected  by  the  Affymetrix
GeneChip Operating Software (GCOS) v 1.4. Genotypes were
generated using the GTYPE software for BRLMM analysis
using  default  settings.  To  evaluate  common  homozygous
regions,  microsatellite  markers  were  typed  in  all  family
members. Information on primer sequences and the physical
location of the markers was obtained from the NCBI database
and  from  the  UCSC  browser,  respectively.  Amplification
conditions were an initial denaturation of 94 °C for 3 min,
followed by 28 cycles of 30 s denaturation at 94 °C, 30 s
annealing at 55 °C, and 30 s extension at 72 °C with a final
extension at 72 °C for 5 min. The amplified fragments were
detected  by  an  automated  ABI  3730  DNA  Analyzer  and
analyzed  with  Genemapper  v3.0  software  (Applied
Biosystems Inc., Foster City, CA).
Mutational analysis: The family members were screened for
mutations in TMEM126A by direct sequencing. The genomic
DNA sequence of this gene was taken from Ensembl, and
primer pairs for the translated exons were designed using
primer3 software . The exons were amplified by PCR using
BioMix™ Red (Bioline Ltd., London, UK). Amplification
conditions were an initial denaturation of 95 °C for 5 min,
followed by 35 cycles of 30 s denaturation at 95 °C, 1 min
annealing at 60 °C, and 1 min extension at 72 °C with a final
extension at 72 °C for 5 min. PCR products were cleaned up
with MicroCLEAN (Web Scientific, Crewe, UK) and were
directly  sequenced  by  the  BigDye  Terminator  Cycle
Sequencing System using ABI PRISM 3730 DNA Analyzer
(Applied Biosystems Inc.). DNA sequences were analyzed
using Chromas software.
RESULTS
Clinical findings: The ophthalmologic findings of the two
affected siblings are summarized in Table 1. Both subjects had
poor vision from birth and complained of a continued gradual
reduction in vision over time. Patient IV:2 had evidence of a
right exotropia and bilateral horizontal nystagmus. Neither
patient had any evidence of residual color vision. Examination
of the anterior segment was normal in both patients. Fundus
examination revealed marked bilateral temporal optic nerve
pallor in both patients with otherwise normal retinal findings
(Figure 1). Goldmann perimetry identified bilateral visual
field constriction in both patients. Retinal nerve fiber layer
analysis revealed bilateral marked reduction in nerve fiber
layer  thickness  in  both  subjects  (Patient  IV:1—average
thickness 38.7 μm right eye, 40.2 μm left eye; range 41.0–
54.0 μm. Patient IV:2—average thickness 40.7 μm right eye,
47.3 μm left eye; range 44.0–49.0 μm; Figure 2).
Full-field ERGs were normal in both patients, with no
evidence of generalized retinal dysfunction (Figure 3). Pattern
reversal  VEPs  from  both  patients  were  grossly  abnormal
(Figure 4). In patient IV:2, pattern VEPs recorded to a large
checkerboard field were delayed with an abnormal waveform
bilaterally  (Figure  4).  Pattern  VEPs  to  a  standard
checkerboard were undetectable on the right, with only a
Figure  6.  Pure  tone  audiograms  of
patient IV:1 (A) and patient IV:2 (B) to
show  absence  of  air-bone  gap  (i.e.,
conductive hearing loss), as judged by
masked and unmasked bone conduction
thresholds.  AC  represents  air
conduction.
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657Figure 7. Measurement stapedial reflex thresholds. This image is the tympanogram and ipsilateral (A) and contralateral (B) stapedial reflex
threshold recordings of patient IV:1 illustrating elevated and/or absent reflexes.
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658delayed residual component on the left (data not shown). In
patient  IV:1,  pattern  VEPs  were  recorded  to  a  standard
checkerboard  and  were  grossly  abnormal.  Flash  VEPs  in
patient IV:1 had an abnormal waveform of low amplitude
bilaterally and revealed no definite abnormality in patient IV:
2 (Figure 4). The pattern ERG N95:P50 ratio was subnormal,
Figure 8. Measurement stapedial reflex thresholds. This image is the tympanogram and ipsilateral (A) and contralateral (B) stapedial reflex
threshold recordings of patient IV:2 illustrating elevated and/or absent reflexes.
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659and the P50 was of short peak time bilaterally in both patients
(Figure 4). These VEP and pattern ERG abnormalities are
consistent  with  bilateral  retinal  ganglion  cell/optic  nerve
dysfunction.
Audiologically, neither child complained of any auditory
or vestibular symptoms. Patient IV:1 showed a very mild low
frequency loss of auditory sensitivity in both ears on pure tone
audiometry when first tested at the age of 17 years, and this
minor  loss  progressed  to  involve  the  500–4,000  Hz
frequencies in the right ear and the 8,000 Hz frequency in the
left ear, 1 year later (Figure 5A). Patient IV:2 showed a 25 dB
loss at 8 kHz in the left ear on three audiograms between the
ages  of  15  and  16  years  (Figure  5B).  Neither  sibling
demonstrated a conductive loss, as judged by a masked bone
conduction  threshold  at  500  Hz  in  patient  IV:1  and  an
unmasked bone conduction threshold at 2,000 Hz in patient
IV:2  (Figure  6A,B).  In  both  siblings,  impedance  studies
revealed normal tympanic membrane compliance and middle
ear pressures, but stapedial reflex thresholds, recording both
ipsilaterally and contralaterally from each ear, were absent in
patient IV:1 (Figure 7A,B) and elevated or absent in patient
IV:2 (Figure 8A,B). Transient evoked otoacoustic emissions
were normal in both children (Figure 9A,B), but brainstem-
evoked  responses  were  abnormal.  In  patient  IV:1,  the
Figure 9. Transient evoked otoacoustic emissions. Transient otoacoustic emission recordings from each ear in patient IV:1 (A) and patient
IV:2 (B) to illustrate normal cochlear outer hair cell function.
TABLE 2. BRAINSTEM EVOKED WAVE LATENCIES AND INTERWAVE INTERVALS FOR SIBLINGS AND NORMAL DEPARTMENTAL RANGES (MEAN±2SD).
Wave 1 Wave III Wave V I-III                         III-V                       I-V
Sister IL 1.8 1.54 3.82 3.62 ~5.24 ~5.12 2.02 2.08 ~1.96 1.6 ~3.98 3.68
Normal range              1.3–1.9 3.3–4.1 5.2–6.0 1.6–2.4 1.4–2.2                   3.6–4.4
Brother IL                                                   Absent                                                    -              -                 -            -                -              -
Abbreviations: R represents right; L represents left, IL represents ipsilateral recording.
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R           L             R            L                R               L              R            L                R            L             R             L Patientresponses  were  of  poor  morphology  ipsilaterally  (Figure
10A), although waves I and III were present and of normal
latencies (Table 2) but wave V could not be well defined.
Recording contralaterally, stimulating the left ear the response
morphology was markedly abnormal and stimulating the right
ear the response was absent. In patient IV:2, all responses were
absent (Figure 10B).
Genetic linkage studies: Genome-wide genotyping using the
Affymetrix 250 k SNP microarrays revealed four extended
regions of homozygosity (>2 Mb; on chromosomes 10 [2 Mb;
from  rs3127234  to  rs912889],  11  [24.17  Mb;  from
rs10793396 to rs10895556], 16 [15.16 Mb; from rs17839519
to  rs7203695],  and  19  [2.18  Mb;  from  rs670091  to
rs1654348]) shared at least by the two affected siblings. For
chromosome 16, all four children showed an almost complete
identical homozygous region of 116 SNPs from 31.63 Mb to
46.79 Mb, including the centromere. Since similar haplotypes
could  be  detected  frequently  in  individuals  with  other
phenotypes  and  with  different  ethnic  backgrounds,  it  was
assumed that this was unlikely to be a specific finding, and
the  chromosome  16  candidate  region  was  not  further
analyzed. Additional genotyping was then performed in all
family  members  using  microsatellite  marker  analysis.
Linkage  to  the  regions  on  chromosome  10  and  19  was
excluded by the finding of heterozygous alleles in affected
individuals  (data  not  shown).  However,  genotyping  of
microsatellite  markers  within  the  candidate  region  at
11q14.1–11q22.3 confirmed that affected individuals were
homozygous  and  unaffected  siblings  were  heterozygous
(Figure 11).
Mutation  analysis  of  the  candidate  gene:  The  24.17  Mb
chromosomal  region  at  11q14.1–11q22.3  contained  175
known  genes,  pseudogenes,  and  hypothetical  proteins.
Interestingly,  the  TMEM126A  gene  that  was  recently
described  in  association  with  autosomal  recessive  optic
atrophy was located within this candidate interval. Therefore,
direct  sequencing  of  TMEM126A  was  undertaken,  and  a
nonsense mutation was detected in exon 3 of this gene (c.
163C>T; p.Arg55X; Figure 12). The mutation co-segregated
with the disease phenotype and was found to be homozygous
in all affected individuals and heterozygous in both parents.
Previously, this mutation was not detected in 700 control
chromosomes [4].
Figure 10. Auditory brainstem-evoked responses. A: Auditory brainstem-evoked responses for patient IV:1 (right ear upper section and left
ear lower section). B: Auditory brainstem-evoked responses for patient IV:2 (right ear upper section and left ear lower section). In patient IV:
1 the responses were of poor morphology ipsilaterally. Recording contralaterally, stimulating the left ear the response morphology was
markedly abnormal and stimulating the right ear the response was absent. In patient IV:2 all responses were absent. Abbreviations: ipsi
represents ipsilateral recording; contra represents contralateral.
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661DISCUSSION
We identified a homozygous nonsense mutation (c.163C>T;
p.Arg55X)  in  TMEM126A  in  an  Algerian  family  with
recessive optic atrophy. The same mutation was identified
previously in four North African families (one Algerian, one
Tunisian, and two Moroccan) with a similar ocular phenotype
(haplotyping  was  consistent  with  a  founder  mutation
originating ~2,400 years ago [~80 generations]) [4]. However,
no further mutations were identified in a cohort of 48 patients
with nonsyndromic optic atrophy (in whom mutations in optic
atrophy  1  gene  [OPA1]  and  the  most  frequent  LHON
mutations  [mitochondrial  DNA  {mtDNA}  G11778A,
G3460A, T14484C, and G15257] had been excluded) [4]. To
date, all patients with TMEM126A mutations, including the
cases reported herein, are of Maghrebian origin and all carry
an identical mutation.
The  families  described  by  Hanein  et  al.  [4]  were
characterized by early-onset severe visual impairment, optic
disc pallor, and central scotomata. The oldest affected patient
lost peripheral visual field function between the ages of 30
and  37.  One  patient  also  had  moderate  hypertrophic
cardiomyopathy, and another displayed mild hearing loss and
minor  brain  alterations  on  magnetic  resonance  imaging
(homogeneous  punctate  hyperintensities  in  the  stratum
subependymale).
Figure 11. Pedigree diagram and haplotype analysis of the Algerian
family  with  autosomal  recessive  optic  atrophy  and  auditory
neuropathy.  The  genotyping  of  microsatellite  markers  on
chromosome 11q14.1–11q22.3 (localization of markers according to
NCBI build 36.3) shows a common haplotype indicated by the black
framed boxes in the two affected members (IV:1 and IV:2). Open
squares represent unaffected males, open circles represent unaffected
females,  solid  squares  represent  affected  males,  solid  circles
represent  affected  females,  and  the  double  line  represent
intermarriage.
Our findings suggest that auditory neuropathy may be a
key feature of TMEM126A-associated optic atrophy. Both
siblings  demonstrated  a  very  mild  but  progressive
sensorineural hearing loss, with no evidence of a conductive
loss,  and  normal  cochlear  function,  as  judged  by  normal
otoacoustic  emissions;  but  both  demonstrated  abnormal
retrocochlear  function,  with  inner  hair  cell/neural
involvement,  as  judged  by  abnormal  stapedial  reflex
thresholds and brainstem-evoked responses. The site of the
neural lesion may lie in the functional unit comprised of inner
hair cells, the primary afferents (spiral ganglion neurons), and/
or the first order synapses between hair cells and the cochlear
nerve.
TMEM126A encodes a mitochondrial protein found in
higher  eukaryotes  [4].  Laboratory  analysis  of  respiratory
chain  function  in  patients  with  homozygous  TMEM126A
mutations has not shown consistent abnormalities (although
one patient demonstrated partial deficiency of Complex I).
Retinal ganglion cells are located in the inner retina and their
Figure 12. Sequence chromatogram of the transmembrane protein
126A  gene  mutation  in  the  optic  atrophy  family,  and  their
corresponding  normal  sequence.  A:  This  panel  shows  the
chromatogram of a control sample with wild-type allele. B: This
panel  shows  the  chromatogram  of  the  mother  (III:1)  with  the
heterozygous  transmembrane  protein  126A  gene  (TMEM126A)
mutation (c.163C>T). C: This panel shows the chromatogram of an
affected individual (IV:1) with the homozygous TMEM126A variant
(c.163T). The black framed box indicates the mutation position.
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662axons remain unmyelinated until they exit the globe and are
organized in bundles to form the optic nerve. During their
intraocular  path,  the  unmyelinated  axons  are  very  energy
dependent  (to  transmit  the  action  potential)  and  therefore
vulnerable in disorders of mitochondrial function [16]. Hence,
optic atrophy is a common feature of mitochondrial disorders,
and two other nonsyndromic causes of optic atrophy, LHON
and autosomal dominant optic atrophy Kjer type, are caused,
respectively, by mutations in mitochondrial DNA and the
nuclear gene OPA1 that encodes a mitochondrial protein. In
addition, optic atrophy is a prominent feature of many other
neurodegenerative diseases caused by primary mitochondrial
dysfunction  [16].  Hearing  loss  is  a  common  feature  in
mitochondrial  disease,  although  frequently  cochlear
dysfunction is reported and auditory neuropathy is considered
a rare finding [5].
Interestingly,  mutations  in  OPA1,  although  originally
described in nonsyndromic hereditary optic neuropathy, have
recently been reported to also cause a syndromic form of optic
atrophy associated with sensorineural deafness, ataxia, and
multiple mitochondrial DNA deletions [17,18]. The hearing
loss is reported to be suggestive of an auditory neuropathy,
while  in  Wolfram  Syndrome  or  diabetes  insipidus  and
mellitus  with  optic  atrophy  and  deafness  (DIDMOAD),  a
recent  clinicopathological  study  reported  cochlear
histopathological abnormalities with loss of the organ of Corti
in the basal turn of the cochlea and mild focal atrophy of the
stria vascularis [19].
Our  findings  suggest  that  a  diagnosis  of  autosomal
recessive TMEM126A-associated optic atrophy and auditory
neuropathy (ARTOAN) should be considered in patients with
optic  atrophy  and  deafness.  Furthermore,  patients  with
homozygous TMEM126A mutations should be investigated
for subclinical evidence of auditory neuropathy.
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